Scottsdale clinic offers life-saving chemo for breast cancer patients
- Morrow, a breast cancer patient, received personalized chemotherapy at Envita Medical Centers after traditional treatments were ineffective.
- She relied on intravenous nutrition for nearly three months and experienced minimal side effects from the new treatment.
- The high cost of GTFC and lack of insurance coverage led her family to raise funds, highlighting the financial barriers many cancer patients face.
In Scottsdale, Arizona, a woman named Morrow underwent a personalized form of chemotherapy known as genetically targeted fractionated chemotherapy (GTFC) after traditional chemotherapy failed to provide effective treatment. Initially, she was unable to consume food orally and relied on intravenous nutrition for nearly three months. Morrow credits her survival to the innovative care she received at Envita Medical Centers, where the treatment is tailored to the patient's genetic makeup and tumor biology, minimizing damage to healthy cells. Although GTFC has fewer side effects compared to traditional chemotherapy, the high cost of treatment poses a significant barrier for many patients. Morrow's family raised nearly $120,000 through a GoFundMe campaign, and they also took out a second mortgage to cover the remaining expenses, as her insurance did not provide coverage for this unconventional treatment. While GTFC can be effective for various types of cancer, it is not universally accessible, and not all patients may qualify for this treatment option. The case highlights the challenges faced by cancer patients in affording personalized medical care and the importance of innovative treatment approaches in improving survival rates.